Background—The goal of this statement is to review available literature and to put forth a
scientific statement on the current practice of fetal cardiac medicine, including the diagnosis …

Noninvasive prenatal genetic testing (NIPT) is an advance in the detection of fetal
chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant …

Disclaimer: This statement is designed primarily as an educational resource for clinicians to
help them provide quality medical services. Adherence to this statement is completely …

Background Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-
risk women. However, there have been few direct, well-powered studies comparing cfDNA …

Background In high-risk pregnant women, noninvasive prenatal testing with the use of
massively parallel sequencing of maternal plasma cell-free DNA (cfDNA testing) accurately …

Objectives To report the clinical performance of massively parallel sequencing‐based non‐
invasive prenatal testing (NIPT) in detecting trisomies 21, 18 and 13 in over 140 000 clinical …

Non‐invasive prenatal testing (NIPT) for aneuploidy using cell‐free DNA in maternal plasma
is revolutionizing prenatal screening and diagnosis. We review NIPT in the context of …

Objective We sought to report on laboratory and clinical experience following 6 months of
clinical implementation of a single-nucleotide polymorphism–based noninvasive prenatal …

Objective The recently developed noninvasive prenatal test (NIPT) presents a new era of
prenatal screening. Previously reported studies were primarily conducted on high‐risk and …

Objective To assess whether preimplantation genetic screening (PGS) is possible by testing
for free embryonic DNA in spent IVF media from embryos undergoing trophectoderm biopsy …